Ads
    Related paper
  1. VALUE OF EPICARDIAL ADIPOSE TISSUE ASSESSMENT BY CARDIAC COMPUTERIZED TOMOGRAPHY IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION
  2. Galectin-3, advanced glycated end-products serum levels, endothelial function and cardiac hemo­dynamics in post infarction heart failure patients with reduced and preserved ejection fraction
  3. The Heart Rate Variability in Patients with Obesity and Heart Failure with a Preserved Ejection Fraction
  4. HEART RATE VARIABILITY IN PATIENTS WITH METABOLIC SYNDROME AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
  5. TNF-ALPHA AND SERUM GALECTIN-3 IN NON DIABETIC PATIENTS WITH HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
  6. Association between Subclinical Hypothyroidism and Cardiovascular Mortality in Patients Suffered from Heart Failure with Preserved Ejection Fraction
  7. The Alteration of Gut Microbiota Between Patients with Left Ventricular Ejection Fraction Preserved and Reduced Heart Failure |Biomedgrid
  8. Clinical features of chronic heart failure with preserved ejection fraction in patients with essential arterial hypertension
  9. Left Ventricular Remodeling in Patients with Stable Angina Complicated by Heart Failure with Reduced and Preserved Ejection Fraction
  10. Blood presure variability in patients with obstructive sleep apnea syndrome and heart failure with preserved ejection fraction